ANTIMANIA DRUGS MARKET ANALYSIS(2020-2027) - PowerPoint PPT Presentation

View by Category
About This Presentation



Read here the market research report on the “Antimania Drugs Markett” published by CMI team – PowerPoint PPT presentation

Number of Views:6
Date added: 3 November 2020
Slides: 17
Provided by: kunalbhuta


Write a Comment
User Comments (0)
Transcript and Presenter's Notes


  • Coherent Market Insights
  • Market Research and Business Consulting Services
  • https//
  • COVID-19 Impact Tracker

  • Antimania Drugs Market, by Drug (Lithium Salts,
    Carbamazepine, Valproic Acid, Lamotrigine,
    Olanzapine, and Others), by Distribution Channel
    (Hospital Pharmacies, Retail Pharmacies, and
    Online Pharmacies), and by Region (North America,
    Latin America, Europe, Middle East, Asia Pacific,
    and Africa) - Size, Share, Outlook, and
    Opportunity Analysis, 2020 - 2027

  • Antimania drugs are used in the treatment of
    bipolar disorder, a type of mood disorder also
    called as manic depression or manic-depressive
    illness, where patients mood fluctuate from
    feeling depressed to feeling super charged or
  • The most widely used medication for the treatment
    of acute mania include lithium, valproate
    carbamazepine (antipsychotics), ziprasidone,
    aripiprazole clozapine (atypical
    antipsychotics), and lorazepam (benzodiazepine).
    Additionally, for the treatment of prophylaxis of
    bipolar mood disorder, lithium carbonate and
    lithium citrate are mostly used. Carbamazepine
    reduces transmission of the nerve impulse in the
    brain, which in turn reduces severity of manic
    episodes. Moreover, carbamazepine can be used as
    alternative to lithium salts, when patients fails
    to respond to lithium. Furthermore, sometimes
    carbamazepine are used with the combination of
    lithium, when there is need of rapid control of
    acute mania.

  • Global Antimania Drugs Market Drivers  
  • The global antimania drugs market is expected to
    witness significant growth over the forecast
    period, owing to growing prevalence of bipolar
    disorder, globally. For instance, according to
    the World Health Organization (WHO) 2019 report,
    around 45 million people get affected by bipolar
    disorder globally.
  • Moreover, cost effectiveness of drugs for the
    treatment of bipolar disorder is another factor
    that is expected to drive the global antimania
    drugs market growth over the forecast period. For
    instance, cost of olanzapine is US 153, while
    cost of lithium is US 16 per month.

  • Furthermore, increasing number of clinical trials
    of drug for the treatment of bipolar depression,
    which is expected to propel the global antimania
    drugs market growth over the forecast period. For
    instance, in July 2018, Lumateperone received
    positive results from the Phase 3 clinical trial
    (Study 401 and Study 404) for the treatment of
    bipolar depression, announced by Intra-Cellular
    Therapies, Inc. In both the trials (Study 401 and
    Study 404), Lumateperone was found safer and
    tolerable by patients.
  • Moreover, in October 2019, Psychiatry Consortium,
    which is a strategic collaboration of leading
    medical research charities and pharmaceutical
    companies to accelerate innovative drug discovery
    in psychiatric diseases, had announced to launch
    a novel drug project to address people with
    mental health conditions such as bipolar
    disorder, depression and other mental disorders.

  • Psychiatry Consortium is a pioneering
    collaboration between the pharmaceutical
    companies, healthcare companies as well as
    leading medical charities. Therefore, increasing
    initiatives by companies to support the novel
    drug project, which in turn, is expected to
    increase the launch of new drugs for treatment of
    patients with mental health condition such as
    bipolar disorder and hence drives the global
    antimania drugs market growth.

  • Global Antimania Drugs Market Restraints
  • However, side effects associated with lithium for
    the treatment of bipolar disorder is one of the
    major factors that is expected to restrain the
    global antimania drugs market growth over the
    forecast period. For instance, if patient takes
    overdose of lithium, it causes anorexia. 
    Moreover, prolong use of lithium can damage
    bodys ability to respond properly to
    the hormone vasopressin and can result into
    diabetes insipidus.

  • Global Antimania Drugs Market Regional Analysis
  • North America is expected to hold the highest
    market share in global antimania drugs market,
    owing to factors such as increasing technological
    advancements such as BiAffect app by  University
    of Illinois, Chicago that helps to facilitate
    accurate detection of a patients mood and mental
    state. For instance, in 2018, the University of
    Illinois, Chicago (UIC) launched BiAffect app,
    which helps to track manic disorder and
    depressive mood in the patient with biopolar
    disorder. Moreover, BiAffect app predict mood
    episodes by analyzing the stroke dynamics such as
    error and typing speed of the patient. Therefore,
    launch of BiAffect app is expected to drive
    demand of antimania drugs for the treatment of
    bipolar disorder.

  • Moreover, increasing approvals of drug such as
    Vraylar by U.S Food and Drug administration (FDA)
    for the treatment of bipolar disorder is another
    factor that is expected to boost global antimania
    drugs market growth. For instance, in May 2019,
    Allergan plc and Gedeon Richter Plc announced to
    receive the approval from the U.S Food Drug
    Administration for expanded use of
    Vraylar (cariprazine) in the treatment of
    depressive episodes associated with bipolar I
    disorder (bipolar depression) in adults.
  • Among regions, Europe is expected to hold the
    second highest market share in global antimania
    drug market, owing to increasing launches of new
    drugs for the treatment of bipolar disorder in
    Europe. For instance, in September 2019, LATUDA,
    an atypical antipsychotic agent was launched by
    Sumitomo Dainippon Pharma Co., Ltd., in China.
    LATUDA is used for the treatment bipolar
    depression. Additionally, the National Medical
    Products Administration (NMPA) has granted import
    drug license for LATUDA drug in China.

  • Global Antimania Drugs Market Key Players
  • Key players operating in the global antimania
    market are Eli Lilly and Company, Sumitomo
    Dainippon Pharma Co., Ltd, Allergan plc, Xian
    Janssen Pharmaceutical Ltd, Pfizer Inc., Otsuka
    Pharmaceutical, Taro Pharmaceutical Industries
    Ltd, Apotex Inc., Teva Pharmaceutical Industries
    Ltd, and Torrent Pharmaceutical Ltd.

  • Market Taxonomy
  • On the basis of drug, the global antimania drugs
    market is segmented into
  • Lithium Salts
  • Carbamazepine
  • Valproic Acid
  • Lamotrigine
  • Olanzapine
  • Others

  • On the basis of distribution channel, the global
    antimania drugs market is segmented into
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • On the basis of region, the global antimania
    drugs market is segmented into
  • North America
  • Latin America
  • Europe
  • Middle East
  • Asia Pacific
  • Africa

  • Request Sample Report
  • Request Customization
  • Download PDF Brochure
  • Talk to Analyst
  • Buy Now
  • Reference https//

About Us
  • Coherent Market Insights is a global market
    intelligence and consulting organization focused
    on assisting our plethora of clients achieve
    transformational growth by helping them make
    critical business decisions.
  • What we provide
  • Customized Market Research Services
  • Industry Analysis Services
  • Business Consulting Services
  • Market Intelligence Services
  • Long term Engagement Model
  • Country Specific Analysis

Contact Us
  • Mr. Shah
  • Coherent Market Insights Pvt.Ltd.
  • Address 1001 4th Ave, 3200 Seattle, WA 98154,
  • Phone 1-206-701-6702
  • Email

  • Thank You!
  • Kindly follow CMI Social Media
    Profiles for the latest company updates
  • Facebook
  • Linkedin
  • Twitter
  • https//